- Home
- FGI vs MBIO Comparison
FGI vs MBIO Comparison
Compare FGI & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGI
- MBIO
- Stock Information
- Founded
- FGI 1987
- MBIO 2015
- Country
- FGI United States
- MBIO United States
- Employees
- FGI N/A
- MBIO N/A
- Industry
- FGI Industrial Specialties
- MBIO Biotechnology: Pharmaceutical Preparations
- Sector
- FGI Industrials
- MBIO Health Care
- Exchange
- FGI Nasdaq
- MBIO Nasdaq
- Market Cap
- FGI 5.5M
- MBIO 4.7M
- IPO Year
- FGI 2022
- MBIO N/A
- Fundamental
- Price
- FGI $0.65
- MBIO $2.65
- Analyst Decision
- FGI
- MBIO
- Analyst Count
- FGI 0
- MBIO 0
- Target Price
- FGI N/A
- MBIO N/A
- AVG Volume (30 Days)
- FGI 163.3K
- MBIO 17.4M
- Earning Date
- FGI 08-06-2025
- MBIO 08-12-2025
- Dividend Yield
- FGI N/A
- MBIO N/A
- EPS Growth
- FGI N/A
- MBIO N/A
- EPS
- FGI N/A
- MBIO N/A
- Revenue
- FGI $134,277,102.00
- MBIO N/A
- Revenue This Year
- FGI $7.72
- MBIO N/A
- Revenue Next Year
- FGI $6.94
- MBIO N/A
- P/E Ratio
- FGI N/A
- MBIO N/A
- Revenue Growth
- FGI 11.13
- MBIO N/A
- 52 Week Low
- FGI $0.46
- MBIO $0.89
- 52 Week High
- FGI $1.20
- MBIO $24.00
- Technical
- Relative Strength Index (RSI)
- FGI 48.82
- MBIO 61.22
- Support Level
- FGI $0.64
- MBIO $2.62
- Resistance Level
- FGI $0.67
- MBIO $3.68
- Average True Range (ATR)
- FGI 0.09
- MBIO 0.59
- MACD
- FGI 0.00
- MBIO 0.18
- Stochastic Oscillator
- FGI 29.03
- MBIO 28.77
About FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.